Search results
Results from the WOW.Com Content Network
By 1983, the USC Norris Comprehensive Cancer Center was opened. Robert E. Tranquada was dean from 1986 to 1991. [17] In 1991, the USC University Hospital, later to be renamed Keck Hospital of USC, was opened. [18] [16] In July 1999, the W. M. Keck Foundation donated $110 million to the USC School of Medicine. The school was then renamed the ...
The Keck Hospital of USC, formerly USC University Hospital, is a private 401–licensed bed teaching hospital of the University of Southern California (USC). The hospital is part of the USC Keck School of Medicine, it is located on the USC Health Sciences Campus, which is adjacent to the Los Angeles General Medical Center, east of Downtown Los Angeles.
In March 2022, Meltzer became the dean of the Keck School of Medicine of USC at the University of Southern California (USC). [3] [4] As dean, she oversees 26 basic and clinical academic programs and 16 major research institutes. She has been instrumental in fostering interdisciplinary research collaborations and expanding the school's clinical ...
Keck School of Medicine of USC people (2 C, 3 P) Pages in category "Keck School of Medicine of USC" The following 9 pages are in this category, out of 9 total.
Anne Peters is a endocrinologist, diabetes expert, and professor of clinical medicine at the Keck School of Medicine of USC. She runs diabetes centers in well-served Beverly Hills and under-resourced East Los Angeles. She teaches physicians and people with diabetes around the world how to better treat the condition, through lifestyle ...
For premium support please call: 800-290-4726 more ways to reach us
The USC Norris Comprehensive Cancer Center is a cancer center in Los Angeles, California owned and operated by the University of Southern California (USC) through its Keck School of Medicine. It was one of the first eight comprehensive cancer centers in the United States, which is devoted to patient care, prevention, research, and education.
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...